Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine for Acute Leber Hereditary Optic Neuropathy
NCT02176733Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Jul 2011
- Primary completion
- Oct 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclosporine in Leber hereditary optic neuropathy (LHON), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Visual Acuity at 9 months. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on NCT02176733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176733.